Julia Moore Vogel

Danilo Buonsenso, a pediatric infectious disease specialist from Rome, and Julia Moore Vogel, an assistant professor and long COVID advocate, dive deep into the complexities of long COVID. They discuss its prevalence across different age groups, the varying definitions of the condition, and the underlying mechanisms like viral persistence and immune dysfunction. With insights on the challenges facing clinical trials and the need for robust pediatric research, they emphasize the importance of tailored management strategies and patient support.

In this insightful discussion, Dr. Alison Cohen, an epidemiologist from UC San Francisco, and Dr. Julia Moore Vogel, a computational biologist at Scripps Research, share their personal journeys with long COVID. They explore the potential of Paxlovid as a treatment, revealing mixed results among patients who extended their usage. The conversation highlights the complex, individualized nature of long COVID symptoms and the urgent need for tailored therapies and further research. Their combined expertise underscores the pressing quest for effective solutions in this evolving health crisis.